PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.\', \'The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.\', \'Department of Medicine IV, Klinikum University of Munich, Munich, Germany.\', \'Service d\'Endocrinologie - Diabète et Nutrition, CHU de Bordeaux, Bordeaux, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1530/EJE-20-0352EJE-20-0352
?:doi
?:hasPublicationType
?:journal
  • European journal of endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 32380475
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.892
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing\'s syndrome.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32380475>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32380475>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all